Canada markets close in 4 hours 29 minutes

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
42.60+0.08 (+0.19%)
As of 11:01AM EDT. Market open.
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
154,495
251,134
605,177
513,354
Other Short Term Investments
695,794
569,614
418,480
595,383
Total Cash
850,289
820,748
1,023,657
1,108,737
Net Receivables
202,260
246,972
213,539
235,221
Inventory
226,669
210,439
180,292
153,073
Other Current Assets
-1
-
-
-
Total Current Assets
1,336,428
1,337,886
1,470,835
1,532,598
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
525,589
516,104
485,445
467,539
Accumulated Depreciation
-331,578
-310,990
-277,208
-255,383
Net property, plant and equipment
194,011
205,114
208,237
212,156
Equity and other investments
404,896
435,189
557,209
459,639
Goodwill
17,231
11,820
7,191
7,191
Intangible Assets
76,144
60,124
19,786
21,662
Other long-term assets
2,117
157
397
126
Total non-current assets
799,085
838,476
936,038
808,654
Total Assets
2,135,513
2,176,362
2,406,873
2,341,252
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
68,484
68,232
61,166
28,858
Taxes payable
33,011
19,695
18,114
22,511
Accrued liabilities
47,008
49,044
40,736
35,811
Deferred revenues
903
5,788
7,583
237
Other Current Liabilities
174,678
229,750
493,013
67,942
Total Current Liabilities
385,548
432,118
676,301
222,731
Non-current liabilities
Deferred taxes liabilities
-
0
1,907
3,395
Deferred revenues
616
919
1,095
1,347
Other long-term liabilities
2,655
4,132
1,571
1,642
Total non-current liabilities
19,106
32,799
35,115
8,762
Total Liabilities
404,654
464,917
711,416
231,493
Stockholders' Equity
Common Stock
680
680
680
679
Retained Earnings
2,414,136
2,388,691
2,338,617
2,725,270
Accumulated other comprehensive income
-174,996
-168,965
-151,621
-163,037
Total stockholders' equity
1,730,859
1,711,445
1,703,649
2,103,864
Total liabilities and stockholders' equity
2,135,513
2,176,362
2,406,873
2,341,252